Anaphylaxis: a new severe allergic reaction with hives, facial/lip swelling, throat tightness, and wheeze after an exposure (a medication, food, or infusion) — a life-threatening emergency. Epinephrine administered per the anaphylaxis protocol/order without delay, the offending exposure stopped, the airway supported and the resident positioned, EMS/transfer activated per policy, and the provider and responsible party notified; the response monitored and a second dose given per protocol if indicated. Skilled recognition and immediate management required. (Airway routes to the Respiratory reference.)

Infection in an immunosuppressed resident: a low-grade fever or a subtle change (malaise, mild tachycardia) in a resident on immunosuppression — potentially a serious infection with a blunted presentation. The provider notified promptly, cultures/labs and evaluation obtained per order, empiric management considered per order, and the resident monitored closely for sepsis; the responsible party notified. Will reassess; supports the Section O/I update. Skilled recognition required, as the usual infection signs may be muted. Alternatively: a severe cutaneous drug reaction (a spreading rash with mucosal involvement/blistering and fever) — the suspected drug stopped, the provider notified urgently, and the resident monitored/transferred per severity (a dermatologic emergency).